XNAS
XRAY
Market cap1.68bUSD
Oct 07, Last price
8.54USD
1D
0.23%
1Q
-28.17%
Jan 2017
-85.21%
Name
DENTSPLY SIRONA Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
Related entities
Subsidiaries (7)
DENTSPLY CANADA LTD.
Dentsply Europe S.a r.l.
DENTSPLY IH LIMITED
DENTSPLY INDIA PRIVATE LIMITED
MAILLEFER INSTRUMENTS HOLDING SARL
Dentsply BX S.a r.l.
MAILLEFER INSTRUMENTS TRADING S.À R.L.
Key people
President, Chief Executive Officer · since 2025
Simon Campion
President, Chief Executive Officer, Interim Principal Financial Officer, Director · since 2024
Andrea Frohning
Chief Human Resources Officer, Senior Vice President · since 2023
Executive Vice President, Chief Commercial Officer · since 2025
Matthew Garth
Executive Vice President, Chief Financial Officer · since 2025
David Ferguson
Senior Vice President, Global Business Unit Leader · since 2025
Kevin Czerney
Chief Accounting Officer, Vice President · since 2024
Robert Johnson
Chief Supply Chain Officer · since 2022
Donald Zurbay
Director · since 2026
Michael Barber
Independent Director · since 2025
Independent Director · since 2011
Brian Gladden
Independent Director · since 2024
Independent Director · since 2018
Independent Director · since 2020
Independent Chairman of the Board · since 2024
Jonathan Mazelsky
Independent Director · since 2023
Independent Director · since 2018
Independent Director · since 2019
IPO date
Aug 12, 1987
Employees
15,000
Domiciled in
US
Incorporated in
US
Legal address
C/O UNITED AGENT GROUP INC.
1521 CONCORD PIKE
SUITE 201
WILMINGTON, DE 19803
US
1521 CONCORD PIKE
SUITE 201
WILMINGTON, DE 19803
US
Headquarters
13220-B Ballantyne Corporate Place
Charlotte, NC 28277
US
Charlotte, NC 28277
US
Previous name
DENTSPLY International Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||